Movement disorder is a neurological condition characterized by unusual or abnormal movements of the body. People with movement disorder may have difficulty walking, talking, and performing other basic tasks. The cause of movement disorders can be varied. It can be caused by changes in brain functioning, diseases such as Parkinson’s, Huntington’s, dystonia, etc., or drug side effects. The basic symptoms of movement disorders are involuntary movements, impaired muscle control, diminished coordination and balance. People with movement disorder may also experience stiffness, tremors, muscle spasms, and difficulty with regular activities. Movement disorder can be diagnosed by a physical and neurological examination along with imaging techniques like X-ray, CT scan, MRI, and ultrasound. Other tests may include pharmaceutical challenge tests, genetic tests, and neuropsychological tests. Treatment of movement disorders depends on the underlying cause. In some cases, medications such as anticholinergics, anti-seizure drugs, and dopamine agonists can be used to control symptoms. Surgery may also be used to correct abnormalities in the area affected by the disorder. In addition, physical therapy, occupational therapy, and speech therapy can also be used to maintain or improve functioning. Living with a movement disorder can be very difficult and often disrupts daily activities. Along with treatments for the movement disorder, it is important to also have support from family and friends. Supportive care can be beneficial in helping a person cope with the difficulties of living with such a disorder. Additionally, proper rest, exercise, and a healthy diet can help a person manage the symptoms of movement disorder.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States